Catalyst Wire Dossier Catalyst Wire Dossier

BC-3781

· Nabriva Therapeutics AG
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BC-3781, covering 2020-10-27 to 2020-10-27. Get the full timeline:

Most recent: Clinical Trial Update: Study Comparing the Safety and Efficacy of Two Doses of BC-3781 vs Vancomycin in Patients With Acute Bacterial Skin and Skin Structure Infection (ABSSSI) [Phase 2]

See pricing